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A B S T R A C T
The present study estimates herpes simplex virus type 2 (HSV-2) seroprevalence and evaluates its association with
age, sex, human herpesvirus type 8 (HHV-8) and human immunodeficiency virus (HIV) among adults in Croatia. A
cross-sectional survey included 166 HIV-infected patients and 219 blood donors. Antibodies against HSV-2 were deter-
mined by enzyme immunoassays based on gG2 recombinant glycoprotein. HSV-2 seroprevalence was 45.8% in HIV-in-
fected patients and 8.7% in blood donors (p<0.0001; OR 8.8; 95% CI 5.05–15.49). Independent predictors of HSV-2
seropositivity were HIV infection (OR 11.0; 95% CI 5.93–20.41), female gender (OR 2.28; 95% CI 1.22–4.26), older age
(OR 3.93; 95% CI 2.74–7.11), and HHV-8 seropositivity (OR 2.72; 95% CI 1.09–6.75). Understanding the epidemiology of
HSV-2 is a critical first step in designing interventions to decrease HSV-2 and HIV transmission. The association of
HSV-2 with HIV infection and HHV-8 antibodies suggests a similar transmission route.
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Introduction
Herpes simplex virus type 2 (HSV-2) is one of the
most common causes of genital ulceration1–3. Genital
herpes is a lifelong incurable infection that causes medi-
cal, psychological and social concerns. There is a syner-
gistic interaction between HSV-2 and HIV1–4. HSV-2 in-
creases risk of HIV acquisition and transmission while
HIV increases clinical and subclinical HSV-2 reactiva-
tion4. Further, HSV-2 reactivation increases HIV viral
load in secretions obtained from genital herpes lesions as
well as in plasma1–4. Accurate type specific HSV serolo-
gical methods facilitate HSV diagnostics, and allow a
better understanding of the burden of infection3,4. The
prevalence of HSV-2 varies in different populations5–10.
HSV-2 antibodies are found more frequently at older age,
in females, in populations with risky sexual behaviour
and in HIV-infected patients1–10.
Human herpesvirus type 8 (HHV-8) seems to share
similar transmission routes as HSV-2, and shows various
prevalences in different populations11,12. Low prevalence
of HIV infection in Croatia has been reported so far13,14.
The seroprevalence of herpes simplex virus type 2
(HSV-2) antibodies in adults in Croatia has as yet not
been described. The aim of the present study is to report
the HSV-2 antibody prevalence in adult HIV-infected pa-
tients compared to blood donors.
Methods
Study population
A cross-sectional study was conducted at the Univer-
sity Hospital for Infectious Diseases, Zagreb, Croatia be-
tween May 1999 and August 2001. The study included
385 participants: 166 HIV-infected patients and 219
blood donors. Age and gender was reported in all subjects
as well as the risk groups in HIV-infected patients.
Serological testing
We analyzed serum samples for antibodies against
HSV-2 and HHV-8. All sera were frozen and stored at
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–20 °C till testing. Antibodies to HSV-2 were determined
by enzyme-linked immunosorbent assays (ELISA) based
on gG2 recombinant HSV-2 specific glycoprotein (ETI-
-HSVK-G 2, DiaSorin, Italy). Equivocal HSV-2 EIA re-
sults led to confirmatory immunoblot (HerpesSelect 1
and 2 Immunoblot IgG, Focus, USA). HHV-8 antibodies
were analyzed with commercially available ELISA (HHV-
-8 IgG Antibody, ABI, Columbia, USA). All tests were
performed and interpreted according to the manufac-
turer’s guidelines.
Statistical analysis
Bivariate associations were evaluated by odds ratio
(OR) and corresponding 95% confidence intervals (CI).
The association of gender, age (dichotomized at 40 years),
and HIV and HHV-8 status with HSV-2 seropositivity
was examined in a multivariable logistic regression mo-
del. Statistical analysis was performed with STATA soft-
ware version 8.0.
Results
HSV-2 antibodies were analyzed in 166 HIV-infected
patients (males, 74.1%) and 219 blood donors (males,
79.0%). The median age for both study groups was 39
years (ranges 19–74 for HIV-infected patients and 18–64
for blood donors). Seventy-three (44.0%) HIV-infected
patients and 116 (53.0%) blood donors were older than
40 years.
The seroprevalence of HSV-2 was 45.8% in HIV-in-
fected patients and 8.7% in blood donors (p<0.0001; OR
8.84; 95% CI 5.05–15.49). Among HIV-infected patients
and blood donors older than 40 years HSV-2 seropre-
valence was 61.6% and 13.9% respectively (p<0.001; OR
9.94; 95% CI 4.89–20.18). Among subjects younger than
40 years 33.3% HIV-infected patients and 2.9% blood do-
nors had HSV-2 antibodies (p<0.001; OR 16.67; 95% CI
4.89–56.83). We found HSV-2 antibodies in 43.9% male
and 51.2% female HIV-infected patients (p=0.48), and
7.5% male and 13.0% female blood donors (p=0.25).
Among HIV-infected men who had sex with men (MSM)
HSV-2 seroprevalence was similar to other risk groups
(52.1% in MSM vs. 43.2% in non-MSM; p=0.31). The
data on HHV-8 has been previously reported (12). Briefly,
the seroprevalence of HHV-8 was 13.3% (22 of 166 sub-
jects) in HIV-infected patients and 4.1% (9 of 219 sub-
jects) in blood donors12.
In our analysis HSV-2-antibodies were associated
with HIV-infection, female gender, older age and HHV-8
seropositivity (Table 1).
Discussion
We found that HSV-2 antibodies were more common
in HIV-infected patients than in blood donors. HSV-2
seroprevalence of 45.8% in HIV-infected patients was
similar to one found in Germany, but lower than in
Coventry, United Kingdom8,9. Higher HSV-2 seropreva-
lence rates in HIV-infected patients have been reported
from Africa (up to 90%) or in clinics where many HIV pa-
tients of African origin are treated9,10. HSV-2 seropre-
valence in Croatian blood donors (8.7%) was similar to
the 4 to 24% range reported by Peabody et al. in the gen-
eral population of different European countries5. How-
ever, direct comparison of seroprevalence studies is diffi-
cult because study populations varied and different
serological tests were used.
HSV-2 antibody status is stated as a surrogate marker
of sexual behaviour. This could explain the higher sero-
prevalence rate in older age. Women generally had a
higher HSV-2 seroprevalence compared to men1–10. In
our study females were 2.33 more likely to have HSV-2
antibodies than males on multivariable analysis. Pea-
body et al.3,5 reported that women were 1.26 to 1.64 more
likely to have HSV-2 antibodies than men in different
European countries.
There is epidemiological and biological evidence of an
interaction between HSV-2 and HIV1–4. The HIV infec-
tiousness is increased in persons coinfected with HSV-2.
HSV-2 reactivation and shedding are more frequent among
those with higher HIV plasma viral load and lower CD4+
T-cells count. HSV-2 increases HIV susceptibility by pro-
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TABLE 1
FACTORS ASSOCIATED WITH THE PRESENCE OF HSV-2 ANTIBODIES AMONG 385 CROATIAN ADULTS:
166 HIV-INFECTED PATIENTS AND 219 BLOOD DONORS
Univariable
(OR; 95% CI)
p value
Multivariable*
(OR; 95% CI)
p value
HIV infection
(yes vs. no)
8.84
(5.05–15.49)
<0.0001
11.00
(6.92–20.41)
<0.0001
HHV-8 antibodies
(yes vs. no)
4.28
(2.02–9.07)
<0.0001
2.72
(1.09–6.75)
0.031
Gender
(male vs. female)
0.64
(0.38–1.08)
0.09
0.43
(0.23–0.82)
0.01
Age
(>40 vs. 40 years)
2.29
(1.47–3.70)
0.001
3.93
(2.17–7.11)
<0.0001
OR – odds ratio; CI – confidence interval
* The odds ratio for each variable was adjusted for all other variables in the table
viding a portal of entry, at which more activated CD4+
T-cells as the target for HIV can be found2–4. Recognition,
diagnostics and treatment of genital herpes might pre-
vent transmission of HIV1–4.
HSV-2 is a well known sexually transmitted agent
that is related with HHV-8, and vice versa11. HSV-2 and
HHV-8 might share similar acquisition modes, although
the exact routes of HHV-8 transmission are still con-
troversial11,12. Mediterranean countries such as Croatia
were labelled as areas with high HHV-8 prevalence11, but
we found that the seroprevalence of HHV-8 in our coun-
try was low (4.1% in blood donors and 13.3% in HIV-in-
fected patients)12.
Limitations of our study should be noted. We used a
convenience sample; however, we studied 166 out of
around 300 HIV-infected patients registered in Croatia
from 1985 till 200113,14. Our subjects demographically re-
sembled the HIV population in Croatia (13,14). Hence,
our results might be generalized for the HIV-infected
population in Croatia.
In conclusion, we found a relatively high HSV-2 sero-
prevalence in HIV-infected patients. HIV infection was
the strongest predictor of HSV-2 seropositivity. Other
factors associated with HSV-2 seroprevalence were age
more than 40 years, female gender and HHV-8 sero-
positivity.
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SEROPREVALENCIJA VIRUSA HERPES SIMPLEX TIPA 2 U ODRASLIH OSOBA ZARA@ENIH
HIV-OM I DOBROVOLJIH DAROVATELJA KRVI U HRVATSKOJ
S A @ E T A K
Prikazani su rezultati istra`ivanja seroprevalencije virusa herpes simplex tipa 2 (HSV-2) u odraslih osoba u Hrvat-
skoj te povezanost HSV-2 s dobi, spolom, humanim herpesvirusom tipa 8 (HHV-8) i virusom humane imunodeficijencije
(HIV). U presje~nu studiju je uklju~eno 166 HIV-inficiranih pacijenata i 219 dobrovoljnih darovatelja krvi. Protutijela
na HSV-2 su odre|ena imunoenzimskim testom koji se temeljio na gG2 rekombinantnim glikoproteinima. Seropre-
valencija HSV-2 u HIV-inficiranih pacijenata bila je 45,8%, a u dobrovoljnih darovatelja krvi 8,7% (p<0.0001; OR 8,8;
95% CI 5,05–15,49). Nezavisni prediktori za HSV-2 bili su HIV-infekcija (OR 11,0; 95% CI 5,93–20,41), `enski spol (OR
2,28; 95% CI 1,22–4,26), starija dob (OR 3,93; 95% CI 2,74–7,11) i seropozitivnost HHV-8 (OR 2,72; 95% CI 1,09–6,75).
Poznavanje epidemiologije HSV-2 je prvi korak u kreiranju mjera za smanjivanje prijenosa HSV-2 i HIV-a. Povezanost
HSV-2 s HIV-infekcijom i protutijelima na HHV-8 upu}uje na sli~an put prijenosa.
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